NY1 |
Breakthrough Drugs Boost Treatment Options for Eczema
NY1 Alexandra Ilyashov doesn't know what triggered her eczema a year and a half ago. It came suddenly, and severly, spreading all over her body. "It was, you know, first maybe the limbs and then suddenly the entire abdomen, chest, back, buttocks," she said … |
Tag Archives: Drugs
Breakthrough Drugs Boost Treatment Options for Eczema – NY1
NY1 |
Breakthrough Drugs Boost Treatment Options for Eczema
NY1 Alexandra Ilyashov doesn't know what triggered her eczema a year and a half ago. It came suddenly, and severly, spreading all over her body. "It was, you know, first maybe the limbs and then suddenly the entire abdomen, chest, back, buttocks," she said … |
The Blood Pressure Drugs that are Linked to Lower Mortality
A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Managed Healthcare Executive – Health Management
I prescribe drugs off-label. Am I in violation of FDA regulations
In a CME session through your local dermatology society, a prominent drug company provides journal articles documenting the off-label use of one of their prescription pharmaceutical agents. You obtain CME credits, read the journal article and begin prescribing the off-label medication. Is the drug company in violation of the U.S. Food and Drug Administration (FDA) rulings? Are your actions acceptable?
Dermatology Times – Dermatology
Seven Ways to Help Patients Access Costly Cancer Drugs
Two new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Managed Healthcare Executive – Health Management
Beta blockers not needed for heart attack survivors taking these drugs
A new study has shocking results about beta blocker use in heart-attack survivors.
Managed Healthcare Executive – Health Management
Beta blockers not needed for heart attack survivors taking these drugs
A new study has shocking results about beta blocker use in heart-attack survivors.
Managed Healthcare Executive – Health Management
Cutaneous side effects of melanoma drugs
Cutaneous side effects of melanoma drugs
Drugs in Perspective: Otezla (apremilast)
Otezla (apremilast), a small-molecule inhibitor of phosphodiesterase 4 (PDE4), was approved by FDA on March 21, 2014, for the treatment of adult patients with active psoriatic arthritis. On September 23, 2014, it was approved for a second indication, the treatment of patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Modern medicine – American Academy of Dermatology